February 1, 2012

As part of DSN's Executive Retailer Viewpoint series, DSN sat down with Jason Reiser, VP health and wellness, ops/compliance at Sam's Club, at DSN's Industry Issues Summit to discuss how to better engage customers and the impact of the economy on business in 2012.

January 18, 2012

In an effort to tap into the minds of some of the industry's top executives, Drug Store News recently sat down and talked with some of these leaders in a multipart executive viewpoint video series.

September 28, 2015

Aurobindo’s latest generic is of Pfizer’s Lopid, which treats high cholesterol alongside diet and exercise.

September 23, 2015

Pfizer Consumer Healthcare is committed to bringing a range of exciting new Centrum multivitamin formulas to market that seamlessly fit into Americans’ everyday lives, the company said.

September 14, 2015

Former Sanofi, Wyeth executive to assume direction of Bayer's North America consumer business. 

September 14, 2015

Mylan announced Monday that it had launched its generic version of Pfizer’s Unasyn (ampicillin and subactam) injection. 

September 4, 2015

Pfizer said that the transaction has strengthened the company’s branded and generics portfolio, particularly when it comes to biosimilars.

August 28, 2015

Alvogen on Wednesday announced that it will acquire a portfolio of four pharmaceutical products in the United States from Pfizer.

August 22, 2015

An executive familiar with the kind of deep data dives that provide actionable insights for OTC companies joins CPR. 

August 20, 2015

Boehringer Ingelheim earlier this week released new data from its clinical trials for its Phase IIIb OTEMTO 1&2 trials, which indicate that Stiolto Respimat provided provided “clinically meaningful improvements” in the St. George’s Respiratory Questionnaire (SGRQ) total score, compared to placebo, in patients with chronic obstructive pulmonary disease, the company said. 

August 20, 2015

Since the launch of Nexium 24HR in May of 2014, the brand has generated approximately $300 million, “making it one of the largest and most successful Rx-to-OTC switches,” Ian Read, Pfizer chairman and CEO, recently told analysts.

August 20, 2015

Sales of OTC products are ramping up significantly with a $1.5 billion gain over the first six months of 2015. 

August 20, 2015

The big story in the digestives space continues to be the switch and launch of Pfizer’s Nexium 24HR. For the 52 weeks ended June 14, sales of Nexium 24HR across total U.S. multi-outlets reached $278.7 million and are still climbing, according to IRI.

August 14, 2015
Pfizer on Friday announced that it would be selling four of its Canadian pharmaceutical products to alleviate concerns from Canada’s Competition Bureau and pave the way for its acquisition of Hospira. 
August 10, 2015
According to Sprout Pharmaceuticals, approximately one-in-three women in the United States suffer from low sexual desire, and one-in-10 women (16 million women total) are distressed by it.
August 6, 2015

Aurobindo Pharma Limited on Tuesday received approval from the Food and Drug Administration for its alprazolam tablets, a generic version of Xanax. 

August 5, 2015

The approval of the acquisition— valued at $17 billion when it was announced in February — is based on Pfizer divesting certain products from its portfolio. 

July 29, 2015

Patients were unable to follow approprate treatment protocols for an OTC Lipitor, so Pfizer decided to discountinue its switch application. 

July 15, 2015

Pfizer and the Arthritis Foundation will work togeher on developing educational tools in support of arthritis. 

July 15, 2015

The new guidelines have been expected to increase the number of statin-eligible adults by almost 13 million.

June 29, 2015

Tris Pharma will supply the new Robitussin long-acting dextromethorphan. 

June 23, 2015

Pfizer has entered into an agreement with GlaxoSmithKline to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for approximately $130 million.

June 15, 2015

Pfizer Consumer Healthcare in May joined the gummy vitamin lineup with the launch of Centrum MultiGummies, adding the leading multivitamin brand to the number of adult gummy vitamin options on the shelf.

June 2, 2015
Aurobindo Pharma Limited has received approval from the Food and Drug Administration for its generic equivalent to Flagyl (metronidazole) tablets in 250- and 500-mg dosage strengths.